A study comparing two approaches, vithoulkas expert system and classical repertorization in selecting Individualised homoeopathic medicine for managing cases of dermatitis.

Comparative analysis between vithoulkas expert system and classical repertorization using radar opus in the management of dermatitis: an open label randomized clinical study. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082524

Enrollment

140

Registered

2025-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L20-L30- Dermatitis and eczema

Interventions

Intervention1: Individualised Homoeopathic medicine: Homoeopathic Medicine shall be given orally in any potency 6c, 30c, 200c, 1M, 10M, CM and LM as per the case and Hahnemannian guidelines of Organon

Eligibility

Inclusion criteria

Inclusion criteria: Patients pre-diagnosed with any forms of dermatitis. Patients with a history of dermatitis for at least 6 months. Patients with mild to moderate severity as assessed by the Eczema Area and Severity Index (EASI) or similar validated tools. Patients who provide written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Patients with severe systemic illnesses or other skin conditions that could interfere with the study (e.g., psoriasis,T2DM etc.). Patients currently on systemic-immunosuppressive therapy or other treatments that could affect the outcome. (e.g. medicine for hypertension, diabetes etc.) Pregnant or breastfeeding women. Patients with a history of non-compliance with medical treatment or those unable to follow up regularly i.e. absenteeism in 3 or more follow ups.

Design outcomes

Primary

Measure	Time frame
According to the scores obtained (pre and post treatment) from the Dermatological Life Quality Index (DLQI) , Peak pruritis numerical rating scale (PP-NRS) and Eczema area and severity index (EASI)Timepoint: Pre scores will be taken at baseline (0 weeks) of treatment and post score will be assessed at 8 weeks, 16 weeks and the end of 24 weeks using Dermatological Life Quality Index (DLQI), Peak pruritis numerical rating scale (PP-NRS) and Eczema area and severity index (EASI)	—

Measure

Time frame

According to the scores obtained (pre and post treatment) from the Dermatological Life Quality Index (DLQI) , Peak pruritis numerical rating scale (PP-NRS) and Eczema area and severity index (EASI)Timepoint: Pre scores will be taken at baseline (0 weeks) of treatment and post score will be assessed at 8 weeks, 16 weeks and the end of 24 weeks using Dermatological Life Quality Index (DLQI), Peak pruritis numerical rating scale (PP-NRS) and Eczema area and severity index (EASI)

—

Secondary

Measure	Time frame
To evaluate the overall difference in how effective these two approaches are at selecting the most suitable (similimum) remedy for managing the symptoms of dermatitis.Timepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Mratyunjay Rajkumar

Dr MPK Homoeopathic Medical College Hospital And Research Centre

homoeopathytoday@gmail.com9785722594

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026